Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel - Brandt, JT; Close, SL; Iturria, SJ (J Thromb Haemost, 2007)
et al.